R
Randy J. Epstein
Researcher at Rush University Medical Center
Publications - 62
Citations - 2341
Randy J. Epstein is an academic researcher from Rush University Medical Center. The author has contributed to research in topics: LASIK & Photorefractive keratectomy. The author has an hindex of 21, co-authored 60 publications receiving 2191 citations. Previous affiliations of Randy J. Epstein include Rush Medical College.
Papers
More filters
Journal ArticleDOI
Topical mitomycin-C for subepithelial fibrosis after refractive corneal surgery.
Parag A. Majmudar,S. Lance Forstot,Richard F. Dennis,Verinder S. Nirankari,Richard E. Damiano,Robert Brenart,Randy J. Epstein +6 more
TL;DR: Topical application of MMC (0.02%) may be a successful method of preventing recurrence of subepithelial fibrosis after debridement and/or keratectomy in patients who have undergone refractive corneal surgery.
Journal ArticleDOI
Role of Orbscan II in screening keratoconus suspects before refractive corneal surgery
TL;DR: In this article, the authors evaluated the relationship between videokeratographic keratoconus screening programs and Orbscan II topography and found that patients with positive krinocus screening tests have higher anterior and posterior elevation on Orbscan 2 topography.
Journal ArticleDOI
A new system, the LipiFlow, for the treatment of meibomian gland dysfunction.
Stephen S. Lane,Harvey Dubiner,Randy J. Epstein,Paul H. Ernest,Jack V. Greiner,David R. Hardten,Edward J. Holland,Michael A. Lemp,James E. McDonald,David I. Silbert,Caroline A. Blackie,Christy A. Stevens,Raman Bedi +12 more
TL;DR: The LipiFlow System was significantly more effective than the iHeat Warm Compress for adults with meibomian gland dysfunction and dry eye symptoms and these results support its safety and effectiveness in the treatment of MGD and Dry eye symptoms.
Journal ArticleDOI
Corneal ectasia after laser in situ keratomileusis in patients without apparent preoperative risk factors.
TL;DR: Ectasia can occur after an otherwise uncomplicated laser in situ keratomileusis procedure, even in the absence of apparent preoperative risk factors, as evaluated in patients who developed ectasia without apparent risk factors.
Journal ArticleDOI
Irreversible corneal decompensation in patients treated with topical dorzolamide
A Konowal,John C. Morrison,S.V.L Brown,D.L Cooke,Leo J. Maguire,D.V Verdier,Frederick T. Fraunfelder,Richard F. Dennis,Randy J. Epstein +8 more
TL;DR: It is suggested that dorzolamide can cause irreversible corneal edema in a subset of glaucoma patients with endothelial compromise, and the findings suggest a rationale for research into the long-term effects of dorZolamide on theCorneal endothelium.